Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin

PHASE3CompletedINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

October 13, 2014

Primary Completion Date

May 3, 2018

Study Completion Date

May 3, 2018

Conditions
Lung Cancer (NSCLC)
Interventions
BIOLOGICAL

Paclitaxel

BIOLOGICAL

Carboplatin

BIOLOGICAL

Ipilimumab

OTHER

Placebo

0.9% sodium chloride injection, USP, or 5% dextrose injection

Trial Locations (49)

1125

Pulmonologiai Klinika, Budapest

2045

Torokbalinti Tudogyogyintezet, Törökbálint

6772

Csongrad Megyei Onkormanyzat Mellkasi Betegsegek Szakkorhaza, Deszk

13125

Local Institution, Berlin

16499

Local Institution, Suwon

21075

Local Institution, Hamburg

28644

Local Institution, Cheongju-si

55131

Local Institution, Mainz

58128

Local Institution, Hwasun-gun

74245

Local Institution, Löwenstein

100032

Local Institution, Beijing

100042

Local Institution, Beijing

100071

Local Institution, Beijing

130012

Local Institution, Changchun

130021

Local Institution, Changchun

169610

Local Institution, Singapore

200025

Local Institution, Shanghai

200030

Local Institution, Shanghai

200032

Local Institution, Shanghai

210000

Local Institution, Nanjing

210002

Local Institution, Nanjing

308433

Local Institution, Singapore

310003

Local Institution, Hangzhou

310009

Local Institution, Hangzhou

310016

Local Institution, Hangzhou

310022

Local Institution, Hangzhou

350025

Local Institution, Fuzhou

400038

Local Institution, Chongqing

400042

Local Institution, Chongqing

410008

Local Institution, Changsha

510060

Local Institution, Guangzhou

510080

Local Institution, Guangzhou

510120

Local Institution, Guangzhou

515041

Local Institution, Shantou

610041

Local Institution, Chengdu

710038

Local Institution, Xi'an

710061

Local Institution, Xi'an

Unknown

Local Institution, Zhengzhou

Local Institution, Changsha

Local Institution, Fuzhou

Local Institution, Kunming

06120

Local Institution, Halle

04357

Local Institution, Leipzig

82-300

Oddzial Onkologiczny, Elblag

60-569

Oddzial Chemioterapii, Poznan

02-781

Klinika Nowotworow Pluca i Klatki Piersiowej, Warsaw

03722

Local Institution, Seoul

05368

Local Institution, Seoul

06351

Local Institution, Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY